Why West Pharmaceutical Services (WST) is a Top Growth Stock for the Long-Term

Company Overview - West Pharmaceutical Services is a leading global manufacturer specializing in injectable drug packaging, delivery systems, and contract manufacturing solutions [12] - The company's product portfolio includes Proprietary Products such as elastomer components, seals, stoppers, syringes, and advanced delivery systems like SmartDose, as well as Contract Manufacturing for pre-filled pens, auto-injectors, and other complex devices [12] - High-Value Products (HVPs) accounted for nearly 45% of revenue in the second quarter of 2025, indicating strong demand from biologics, specialty injectables, and next-generation therapies [12] Investment Ratings - West Pharmaceutical Services holds a 2 (Buy) rating on the Zacks Rank, with a VGM Score of B [13] - The company is considered a top pick for growth investors, with a Growth Style Score of B, forecasting year-over-year earnings growth of 7.3% for the current fiscal year [13] - Five analysts have revised their earnings estimates higher in the last 60 days for fiscal 2026, with the Zacks Consensus Estimate increasing by $0.18 to $7.82 per share [13] Performance Metrics - West Pharmaceutical Services boasts an average earnings surprise of +17.4%, indicating strong performance relative to expectations [13] - With a solid Zacks Rank and top-tier Growth and VGM Style Scores, the company is recommended for investors' consideration [14]